Oxygenators are a type of medical device that is frequently used in hospitals. They can exchange oxygen and carbon dioxide and are used in medical procedures. This gaseous exchange may occur while the patient is undergoing surgery, and in such cases, the therapy may necessitate the interruption of blood supply to a critical organ. To deal with the current COVID-19 situation, companies are increasing oxygenator production around the world to aid in the adoption of ECMO techniques for the treatment of COVID-19 patients. The use of oxygenators in intensive care units has skyrocketed. Furthermore, because these devices are critical components of critical care in surgical procedures and COVID-19 patient management, market companies are introducing solutions that include an oxygenator. COVID-19 will have an impact on the production of oxygenator items in 2020. Furthermore, the postponement of elective treatments as a result of COVID-19-related activities, particularly in the first half of 2020, harmed medical devices such as oxygenators.
An increase in the global prevalence of cardiovascular diseases, as well as changing lifestyles, is expected to drive the market. There is a greater acceptance of surgical intervention in cardiac anomaly situations, as well as a greater awareness of health and general well-being. This is expected to benefit the industry even more. The ability of oxygenators to act as a lung substitute during a surgical procedure, exposing the blood to oxygen and removing carbon dioxide, is expected to boost the market even further. However, the introduction of minimally invasive treatments such as percutaneous coronary interventions, the risks associated with oxygenation systems, and strict US FDA rules for Class II category devices that must outperform performance requirements are stifling overall market growth.
The global oxygenators market to increase from US$ 218.1 million in 2021 to US$ 362.6 million by 2029 with a compound annual growth rate (CAGR) of 6.6% for the period 2021-2029. Some of the prominent players in the market are Braile Biomedica, Chalice Medical Ltd, Eurosets SRL, Gen World Medical Devices, Getinge AB, Livanova PLC, MC3 Cardiopulmonary, Medtronic PLC, Microport Scientific Corporation, Nipro Medical Corporation, Owgels Group, Senko Medical Instrument Mfg Co. Ltd, Terumo Medical Corporation and Xenios AG. The research report on the global oxygenator market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the market.
The global economy is highly affected by the COVID-19. Various sectors in the economy are much affected by this pandemic. The global economy will decline because of the loss of trillions of dollars. The growing extension and imposition of lockdown in various countries directly affect the economy all over the world. The report consists of a chapter that provides a detailed study of the impact of COVID-19 on the oxygenator market. This report is helpful for business and industry practitioners. The study specifically intended to assist in explaining, directing, and understanding the potential of the oxygenator markets. The study focuses on providing readers with an understanding of developments in the industry. The report also provides detailed insights on market segments, market forecasts, leading players, market drivers, and inhibitors.
The second chapter, market overview, provides an overview of the oxygenator market. The chapter discusses macroeconomic factors, drivers, restraints, opportunities, challenges, value chain analysis, technology roadmap, and Porter 5 force model analysis.
Chapter 3, segment analysis provides information on the different sub-segments of the market. The chapter provides an in-depth analysis of the market segments, year-on-year growth projections that enable readers to identify potential market growth areas.
Chapter 4, the regional analysis includes an in-depth analysis of the oxygenator market by region. The chapter includes various regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The report also includes a comprehensive analysis of the market by country. The report covers countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers to explore the potential of the market in different geographies. This section is a vital part of the report for each year's growth projections and a global share of value.
Chapter 5, competitive analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.
Chapter 6, the company profile of the report also covers key industry players working in the oxygenator market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.
The study offers an exhaustive summary and estimate of the global market. It includes in-depth qualitative and quantitative analyses in the report that align with our customer's goals and objectives. Projections have been confirmed by comprehensive primary and secondary analysis. The study will encourage clients to invest in the market based on the current business situation, trends, and potential developments in the segments. Understanding the requirement of the client, the report delivers specialist insights into the global market, its products, and market patterns.